INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,713,437 | -20.1% | 1,002,955 | +3.0% | 0.12% | -16.1% |
| Q2 2023 | $39,701,081 | +13.7% | 973,543 | +3.9% | 0.15% | +8.0% |
| Q1 2023 | $34,924,450 | +3.0% | 937,066 | -3.6% | 0.14% | -4.2% |
| Q4 2022 | $33,915,732 | -46.7% | 972,076 | -14.5% | 0.14% | -47.1% |
| Q3 2022 | $63,654,000 | +18.7% | 1,137,475 | +9.8% | 0.27% | +22.5% |
| Q2 2022 | $53,639,000 | -30.2% | 1,036,305 | -1.9% | 0.22% | -16.2% |
| Q1 2022 | $76,795,000 | -42.9% | 1,056,768 | -7.1% | 0.26% | -38.9% |
| Q4 2021 | $134,567,000 | -13.4% | 1,138,104 | -1.8% | 0.43% | -19.9% |
| Q3 2021 | $155,445,000 | -23.0% | 1,158,732 | -7.0% | 0.54% | -21.1% |
| Q2 2021 | $201,832,000 | +89.9% | 1,246,571 | -5.9% | 0.69% | +81.3% |
| Q1 2021 | $106,292,000 | +19.4% | 1,324,429 | -19.0% | 0.38% | +19.6% |
| Q4 2020 | $88,993,000 | +148.1% | 1,635,872 | -9.3% | 0.32% | +123.2% |
| Q3 2020 | $35,876,000 | +9.5% | 1,804,256 | +15.8% | 0.14% | +6.8% |
| Q2 2020 | $32,753,000 | +93.4% | 1,558,163 | +12.5% | 0.13% | +68.4% |
| Q1 2020 | $16,935,000 | -13.4% | 1,384,812 | +3.9% | 0.08% | +6.8% |
| Q4 2019 | $19,554,000 | +16.7% | 1,332,825 | +6.2% | 0.07% | +7.2% |
| Q3 2019 | $16,750,000 | -7.0% | 1,254,767 | +14.1% | 0.07% | -8.0% |
| Q2 2019 | $18,005,000 | +22.4% | 1,099,845 | +15.0% | 0.08% | +23.0% |
| Q1 2019 | $14,715,000 | +55.0% | 956,511 | +37.6% | 0.06% | +32.6% |
| Q4 2018 | $9,492,000 | -55.3% | 695,336 | -6.3% | 0.05% | -47.7% |
| Q3 2018 | $21,237,000 | +18.3% | 742,024 | +13.1% | 0.09% | +12.8% |
| Q2 2018 | $17,945,000 | +44.7% | 655,882 | +11.5% | 0.08% | +41.8% |
| Q1 2018 | $12,404,000 | – | 588,168 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |